Allergan Says Not Focused on ‘Big M&A’ as Sales Fall Short

Updated on
  • Second-quarter revenue lower than analysts anticipated
  • Allergan CEO says not focused on or looking at large deals

Allergan Plc isn’t looking at any large deals, Chief Executive Officer Brent Saunders said, after the drugmaker posted second-quarter sales that fell short of analysts’ estimates.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.